Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4/T3 Therapy in Hypothyroidism
NCT07424183Phase 2Not yet recruiting
- Sponsor
- University of Pennsylvania
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liothyronine in hypothyroidism, sponsored by University of Pennsylvania. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
liothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT07424183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424183.